CNO Financial Group Set to Join the S&P MidCap 400

NEW YORK, April 1, 2015 /PRNewswire/ -- CNO Financial Group (NYSE: CNO) will replace Salix Pharmaceuticals (NASD: SLXP) in the S&P MidCap 400 after the close of trading on Monday, April 6. Valeant Pharmaceuticals (NYSE: VRX) completed the acquisition of Salix Pharmaceuticals earlier today.

CNO Financial Group is a holding company that sells insurance throughout the US. Headquartered in Carmel, Indiana, the company will be added to the S&P MidCap 400 GICS (Global Industry Classification Standard) Life & Health Insurance Sub-Industry index.

Following is a summary of the change:

S&P MidCap 400 INDEX – April 6, 2015
	COMPANY	GICS ECONOMIC SECTOR	GICS SUB-INDUSTRY
ADDED	CNO Financial Group	Financials	Life & Health Insurance
DELETED	Salix Pharmaceuticals	Health Care	Pharmaceuticals

Additions to and deletions from S&P Dow Jones Indices do not in any way reflect an opinion on the investment merits of the companies involved.

About S&P Dow Jones Indices

S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is the world's largest, global resource for index-based concepts, data and research. Home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®, S&P Dow Jones Indices LLC has over 115 years of experience constructing innovative and transparent solutions that fulfill the needs of investors. More assets are invested in products based upon our indices than any other provider in the world. With over 1,000,000 indices covering a wide range of asset classes across the globe, S&P Dow Jones Indices LLC defines the way investors measure and trade the markets. To learn more about our company, please visit www.spdji.com.

S&P® is a registered trademark of Standard & Poor's Financial Services LLC ("S&P"), a part of McGraw Hill Financial. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones").  These trademarks have been licensed to S&P Dow Jones Indices LLC. It is not possible to invest directly in an index. S&P Dow Jones Indices LLC, Dow Jones, S&P and their respective affiliates (collectively "S&P Dow Jones Indices") do not sponsor, endorse, sell, or promote any investment fund or other investment vehicle that is offered by third parties and that seeks to provide an investment return based on the performance of any index. This document does not constitute an offer of services in jurisdictions where S&P Dow Jones Indices does not have the necessary licenses. S&P Dow Jones Indices receives compensation in connection with licensing its indices to third parties.

For more information:

David Blitzer
Managing Director and Chairman of the Index Committee
S&P Dow Jones Indices
([phone]
[e-mail] 

David R. Guarino
Communications
S&P Dow Jones Indices
([phone]
[e-mail]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cno-financial-group-set-to-join-the-sp-midcap-400-300059792.html

SOURCE S&P Dow Jones Indices

Copyright 2015 PR Newswire